Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rheumatology Informatics System for Effectiveness (RISE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02230943
Recruitment Status : Unknown
Verified August 2014 by American College of Rheumatology.
Recruitment status was:  Recruiting
First Posted : September 3, 2014
Last Update Posted : September 3, 2014
Sponsor:
Information provided by (Responsible Party):
American College of Rheumatology

Brief Summary:

The RISE Registry is an enhanced version of the ACR's Rheumatology Clinical Registry (RCR) and allows for a simplified entry process, while establishing a best-in-class resource to manage your patient population and improve patient care.

RISE provides participants with an infrastructure for robust quality improvement activities leading to improved patient outcomes, patient population management and quality reporting related to rheumatic diseases and drug safety. RISE gives physicians and researchers the information they need to optimize patient outcomes, meet reporting requirements, and make discoveries that advance rheumatology.


Condition or disease
Rheumatoid Arthritis Osteoarthritis Gout

Detailed Description:

RISE helps providers benchmark performances on key rheumatology clinical quality measures and align with best practice standards. The RISE benchmarking tool allows providers to view the details of their patient population against established rheumatology quality metrics. RISE allows access to aggregate data from other participating sites so providers can view their patient population in comparison to other RISE participants.

RISE is integrated into an electronic health records (EHR) system, bringing a single point of entry into one solution for filing for quality-based incentive payments, avoiding penalties, complying with reporting requirements and tracking caseloads for quality monitoring and improvement initiatives. RISE collects the data needed to meet current federal reporting requirements.

Participating in RISE helps push the field of rheumatology practice forward. RISE provides a source of information on patient outcomes and quality care for rheumatology leading to new discoveries, better understanding and a source of comparative effectiveness research.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 100000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 1 Year
Official Title: American College of Rheumatology's Rheumatology Informatics System for Effectiveness
Study Start Date : April 2014
Estimated Primary Completion Date : December 2015

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Controlling High Blood Pressure [ Time Frame: one year ]
    Percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90mmHg) during the measurement period.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Primary care clinic
Criteria

Inclusion Criteria:

  • Patients 18 years of age and older with one of the following diagnoses: rheumatoid arthritis, osteoarthritis, gout

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02230943


Contacts
Layout table for location contacts
Contact: Melissa D Francisco 404-633-3777 ext 102 mfrancisco@rheumatology.org
Contact: Rachel Myslinski, MBA 404-633-3777 ext 824 rmyslinski@rheumatology.org

Locations
Layout table for location information
United States, Georgia
American College of Rheumatology Recruiting
Atlanta, Georgia, United States, 30319
Contact: Melissa D. Francisco    404-633-3777 ext 102    mfrancisco@rheumatology.org   
Sponsors and Collaborators
American College of Rheumatology
Additional Information:

Layout table for additonal information
Responsible Party: American College of Rheumatology
ClinicalTrials.gov Identifier: NCT02230943    
Other Study ID Numbers: RISE
First Posted: September 3, 2014    Key Record Dates
Last Update Posted: September 3, 2014
Last Verified: August 2014
Keywords provided by American College of Rheumatology:
rheumatoid
arthritis
osteoarthritis
gout
Additional relevant MeSH terms:
Layout table for MeSH terms
Arthritis
Osteoarthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases